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Abstract
Objectives: To estimate the prevalence of psychiatric
morbidity, substance misuse problems and related health
and social problems among women prisoners newly
committed and a cross-section remanded and sentenced in
the Irish prison population. In 2002 women represented
10.7% (1043) of all persons committed to the Irish Prison
system, and 3.3% (104) of the daily average number of
persons in custody. We surveyed psychiatric morbidity in
these two groups to assess the need for psychiatric
services for women prisoners, and to compare Irish
morbidity with an international average. 
Method: We interviewed 94 newly committed women
prisoners within 72 hours of committal, representing
approximately 9% of female committals per year. We also
interviewed a cross sectional sample of 92 women,
representing approximately 90% of all women in custody.
Mental illness and substance misuse was measured using
the SADS-L, SODQ and a structured interview.
Results: Five (5.4%) of the committal and 5 (5.4%) of the
cross-sectional sample had a psychotic illness within the
previous six months. 8 (8.5%) of the committals and 15
(16.3%) of the women in the cross-sectional sample had a
major depressive disorder in the last six months. 8 (8.6%)
committals and 14 (15.2%) in the cross-sectional sample
had an anxiety disorder within the last six months. 61
(65.6%) of the women interviewed at committal and 61
(65.2%) of the cross-sectional sample had a substance
misuse problem in the last six months.
Conclusions: There is a high prevalence of mental illness
and substance misuse problems amongst women newly
committed to prison and in a cross section of those
remanded or sentenced in prison in Ireland. We found
evidence of a cycle of deprivation and institutionalisation.
These findings highlight the need for the integration of
community and forensic psychiatric services, and for
ongoing collaboration with drug services.
Key words: Psychiatric morbidity; women prisoners; Irish
prison system.
Introduction
Studies of psychiatric morbidity amongst newly committed
prisoners are rare, with very few such studies of women
prisoners.1 A recent meta-analysis2 which included 2,160
remanded and 804 sentenced women prisoners in cross-
sectional but not committal surveys, revealed that 4% of
women prisoners on remand or sentenced had a psychotic
illness and 12% a major depression within the previous six
months, rates that are higher than amongst men prisoners. A
study of psychiatric disorder among a cross-section of
women in one Irish prison3 found that 58% met DSM criteria
for substance misuse and 24% met DSM criteria for other
Axis-1 diagnoses. A national cross-sectional survey of blood
borne viruses in Irish prisoners4 found that women prisoners
were more likely than their male counterparts to report ever
injecting drugs and heroin smoking in the past year. 59.7%
of the women surveyed reported ever injecting, compared to
42.4% of men. 59% of women reported smoking heroin
compared to 42% of men. The same survey5 found that the
prevalence of hepatitis was significantly higher in female
prisoners than male prisoners in Ireland. 
There appears to be a significant pool of mentally ill people
in women’s prisons, and an unmet need for mental health
services. The morbidity in women prisoners appears to be
quantitatively and qualitatively different from men prisoners.
As part of a larger study of psychiatric morbidity and treat-
ment needs in the Irish prisons population6,7 we set out to
estimate the prevalence of psychiatric morbidity, substance
misuse problems and related health and social problems
among women prisoners in the Irish prison population using
research diagnostic methods. There are very few published
studies of psychiatric morbidity in women prisoners on
committal to prison,8 although newly committed prisoners
represent the largest identifiable group passing through the
prison system. We hypothesised that the prevalence of
mental illnesses in newly committed and in cross-sectional
samples of women prisoners should be the same, and also
that the prevalence of mental illnesses in this population
should be comparable to known prevalence in the commu-
nity; or no higher than in prison populations in other
jurisdictions. 
Methods
Ethics
Ethical approval for the study was obtained from the
Research Ethics Committees of the Irish Prisons Service and
the National Forensic Mental Health Service. Voluntary writ-
ten consent was obtained from all those approached to
participate in the study.
Sample and study design
In 2002, women represented 10.7% (1043) of all persons
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committed to prison in Ireland. Of those committals 301 were
sentenced. The daily average number of female prisoners in
that year was 104. Female prisoners represented only 3.2%
of all prisoners in custody in the Republic of Ireland.9 The
majority of women prisoners are detained in The Dochas
Centre, the only female prison in Ireland with a capacity for
approximately 80 inmates, though the capacity is often
exceeded. A smaller number are detained on a female wing
in Limerick Prison, located outside Dublin. 
We considered two populations. In the first survey we
aimed to interview a cross section of all women in prison at
the time of the study. In the second survey we aimed to
assess approximately 10% of all women committed to prison
in the year of the study. 
Cross-sectional sample
For the cross-sectional survey, a list of all women prisoners
in custody was obtained from each of the two women’s pris-
ons by the Irish Prisons Service Information Technology
Department, sorted according to age and time in custody.
Prior to commencing the study, information leaflets were
distributed to prisoners who were then initially approached
by prison officers. All women prisoners were approached to
participate in the study. Those who declined were not
pressed. We visited the Dochas Centre during two separate
sampling periods. Remand prisoners were interviewed from
November 6, 2003 to November 11, 2003, and sentenced
prisoners were interviewed between February 4, 2004 and
February 20, 2004. Women in the small female wing of
Limerick prison were interviewed over two days (August 1,
2002 and September 30, 2002). We approached 102
women prisoners, 10 of whom declined to be interviewed,
giving us a response rate of 87.3%. We interviewed 92
women prisoners, 24 of whom were on remand and 68 were
sentenced.
Committal sample
In 2002 there were 1043 committals of sentenced and
remanded women prisoners, 10.7% of all committals to
prison. For the survey of new committals potential subjects
were drawn from committal lists provided by the prison
receptions, and all committals were approached. Those who
declined to be interviewed were not pressed. Of 208 women
committals during the two sampling periods (August 2003,
April to May 2004), 124 were available, of whom 94 agreed
to be interviewed, 57 (61%) remanded and 37 (39%)
sentenced. We found that even when aiming to interview
women committals within 72 hours of reception in the prison,
40% were not available due to court appearances, visits,
activities or release prior to interview. Of those approached,
31.6% declined to give consent for interview. We interviewed
94 women on committal, representing 9% of 1043 women
committed to prison.
Interview schedule
We used the Schedule for Schizophrenia and Affective
Disorders, Lifetime version (SADS-L),10 to detect current and
lifetime mental disorder. The SADS-L generates diagnoses
according to DSM criteria, almost all of which are inter-
changeable with ICD-10-Diagnostic Criteria for Research.
SADS-L therefore distinguishes major depressive disorder
(DSM-IV-TR,11 equivalent to ICD-10 DCR12 major and moder-
ate depressive disorder combined), from minor depressive
disorder (DSM-IV-TR) which is equivalent to ICD-10 DCR
minor depressive disorder. We have reported diagnoses as
far as possible in keeping with the criteria used in the meta-
analysis by Fazel and Danesh.2 We used the Severity of
Dependence Questionnaire (SODQ) to quantify levels of
drug use and dependence.13 Self-reported levels of alcohol
and drug use were also recorded. We added to these, ques-
tions to clarify the six-month and 12-month prevalences, as
well as the current and lifetime diagnosis. We obtained
demographic, ethnic and personal details using a semi-struc-
tured standardised interview, which was piloted for
acceptability and practicality. Training in the use of the SADS-
L and further interview instruments was followed by joint
interviews to ensure inter-rater reliability. Research interview-
ers were post-membership psychiatrists.
The committal sample was screened for personality disor-
der using the Schedule for Assessment of Personality,
Screening Version (SAPAS).14
We reviewed the prison medical notes of those who
agreed to participate in the study and discussed psychiatric
history with prison medical staff.
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Characteristic Female Female 
Committals Cross-sectional
N = 94 N = 92
Mean age (years) 27.4 31.5
Married (%) 28 (30.1%) 19 (20.7%) 
[95% CI] [21.5-39.7] [13.6-30.0]
Violent offence (%) 14/60 (23.3%) 22/84 (26.2%)
[95% CI] [14.4-35.4] [18.0-36.5]
Nationality % 74 (78.7%) 79 (85.9%)
(Irish origin) [69.4-85.8] [77.3-91.6]
Table 1: Comparison between demographic characteristics of female
committal and cross-sectional samples 
Female Committals (%) Female Cross-Sectional (%)
N=94 N=92
Hepatitis B 4 (4.3) 2 (2.2)
[95 % CI] [1.7-10.5] [0.6-7.6]
Hepatitis C 27 (29.0) 31 (34.1)
[95 % CI] [21.0-39.3] [24.9-43.8]
HIV 6 (6.5) 7 (7.6)
[95 % CI] [3.0-13.4] [3.7-14.9]
Table 2: Prevalence of infectious disease in female prisoners
Prescribed medication Female committal Female cross-sectional
N=94 N=92
Benzodiazepines 29.0% 25.6%
Methadone 35.5% 33.3%
Antidepressant 24.7% 27.8%
Antipsychotic 7.5% 2.2%
Table 3: Medication prescribed prior to imprisonment
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Data analysis
Data was analysed using SPSS 11.0. Within the cross-
sectional sample the remand and sentenced data was
analysed together in view of the small number of participants
involved.
Results
Demographic and social 
Age
The mean age of women in the female committals sample
was 27.4 (SD 8.7) years and 31.5 (SD 11.0) years for the
cross-sectional sample (see Table 1).
Accommodation, marital status and employment
At the time of interview 62% (57) of women in the commit-
tal were single, 30.1% (28) were married or cohabiting, 5.4%
(5)  were separated or divorced and 2.2% (2) were widowed. 
Only 23.7% (22) reported that they had been employed at
the time of committal, while 67.8% (63) were unemployed or
on disability benefit. 3.2% (3) were students. 53.8% (50)
reported a history of homelessness.
In the cross-sectional sample, at the time of interview, 62%
(57) were single, 20.7% (19) were married or cohabiting,
13% (12) were separated or divorced and 13% (12) were
widowed. 77.2% (71) reported being unemployed or on
disability benefit at the time of arrest. 51.6% (47) reported a
history of homelessness. 
Social supports and housing
76.3% (71) of women newly committed to prison and
73.9% (68) of the cross sectional sample of women prison-
ers were living in settled accommodation either with family or
in their own homes. 1.1% (1) of committals and 6.5% (6) of
the cross sectional sample were living in settled hostel
accommodation for greater than one month prior to impris-
onment. 12.9% (12) of committals and 7.6% (7) of the cross
sectional sample were living in unsettled accommodation e.g
bed and breakfast or hostel accommodation for less than one
month. 7.7% (7) of committals and 9.8% (9) of the cross
sectional sample were roofless in the month prior to impris-
onment. 1.1% (1) of committals and 2.2% (2) of the cross
sectional sample were living in official halting sites.
53.8% (50) of committals and 51.1% (47) of the cross
sectional sample reported that they had been homeless at
some stage in their lives. 10.8%(10) of committals and
16.3% (15) of the cross sectional sample reported that they
would have no-where to live when released from prison.
Educational attainment and employment
Of the sample of women newly committed to prison 10.6%
(10) described themselves as illiterate, compared with only
1.1% (1) of the cross-sectional sample. 13.8% (13) of
committals interviewed, and 12% (11) of the cross-sectional
sample attended special school or remedial classes in main-
stream school. 48.9% (46) of the committal sample, and
46.7% (43) of the cross-sectional sample left school without
formal examinations. Only 8.5% (8) of the committals and
7.6% (7) of the cross sectional subjects completed the Leav-
ing Certificate examination. 48.9% (46) of the committals
and 35.9% (33) of the cross-sectional sample reported a
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DSM-IV diagnosis Female Female
Committals (%) Cross-sectional (%)
[95 % CI] N=94 [95 % CI] N=92
Psychosis* 5 (5.4) 5 (5.4)
[2.3-12.0] [2.3-12.1]
Affective disorder** 13 (14.0) 19 (20.7)
[8.4-22.5] [13.6-30.0]
Major depressive disorder 4 (4.3) 15 (16.3)
[1.7-10.4] [10.1-25.2]
Anxiety disorder 8 (8.6) 14 (15.2)
[4.4-16.1] [9.3-23.9]
Substance use disorder 61 (65.6) 61 (65.2)
[63.1-81.8] [56.2-75.1]
Any mental illness 24 (25.8) 36 (39.1) 
[18.0-35.5] [29.8-49.3] 
*Includes schizophrenia, drug-induced psychosis, depressive disorder with psychotic symptoms,
bipolar affective disorder-manic.
**Includes mild, moderate and severe depression without psychotic symptoms, and dysthymia
Table 4: Six-month prevalence of mental illness and substance
misuse in female committals and cross-sectional sample
Psychosis Female Female
Committals (%) Cross-sectional (%)
[95 % CI] N=94 [95 % CI] N=92
Current 5 (5.4) 3 (3.3)
[2.3-12.0] [1.1-9.2]
Six Month 5 (5.4) 5 (5.4)
[2.3-12.0] [2.3-12.1]
Lifetime 10 (10.8) 7 (7.6)
[5.9-18.7] [3.7-14.9]
Table 5: Prevalence of psychotic illness in female committal and
cross-sectional samples
Affective disorders* Female Female
Committals (%) Cross-sectional (%)
[95 % CI] N=93 [95 % CI] N=92
Current 10 (10.8) 15 (16.3)
[5.9-18.7] [10.1-25.2]
Six Month 13 (14.0) 19 (20.7)
[8.4-22.5] [13.6-30.0]
Lifetime 22 (23.7) 39 (42.4)
[6.2-33.2] [32.8-52.6]
Major Affective Disorder**
Current 4 (4.3) 11(12)
[1.3-13.4] [6.8-20.2]
Six month 8(8.5) 15(16.3)
[4.4-15.9] [10.1-25.2]
Lifetime 15(16.1) 34(37)
[8.6-28.2] [27.8-47.2]
*Includes mild, moderate and severe depression without psychotic symptoms, and dysthymia
** Includes ICD-10 F32-33
Table 6: Affective disorders in female committal and cross-sectional
samples
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history of truanting from school. 
Ethnicity
The majority of women interviewed, 78.7% (74) of the
committal sample and 86.8% (79) of the cross sectional
sample were white and from European Union nations. 10.8%
of committals and 6.6% of the cross sectional sample were
non European. The larger number of non-nationals in the
committal sample is accounted for by those on deportation
orders and not charged with a criminal offence. Irish Trav-
ellers were over-represented in both samples and accounted
for 10.6% (10) of the committal sample and 6.5% (6) of the
cross sectional sample, compared to 0.58% of the general
population15 (see Table 1).
Family disruption
The majority of women prisoners interviewed, 61.3% (57)
of committals and 65.2% (60) of the cross sectional sample,
had children. 19.1% (18) of committals and 10.9% (10) of
the cross sectional sample reported being placed into care
or sent to a juvenile detention centre before the age of 16
years. 17.0% (16) of committals and 16.3% (16) of the cross
sectional sample stated that their own children had been
placed into care or had been involved with social workers. 
Women who had themselves been placed in care as chil-
dren were significantly more likely to have children placed in
care compared to those women who had never been in care,
80.4% compared to 22.2% (chi-squared =7.7, p=0.005) of
women in the committal sample, and 70.0% compared to
19.1% (chi-squared =10.6, p=0.001) of women in the cross
sectional sample.
Forensic histories
20.2% (19) of the sample of women newly committed to
prison and 23.3% (95% CI 15.8-33.1) of the cross sectional
sample of women prisoners reported that they had been in
contact with the juvenile court system. The mean number of
previous sentences served was 1.7 for the women commit-
tals and 1.4 for the cross sectional sample. The mean
number of periods on remand was 2.9 for the female commit-
tals and 1.9 for the cross sectional sample.
Medical histories
The self-reported prevalence of blood-borne diseases was
high in both groups (see Table 2). A high proportion of
women in both samples were receiving prescribed benzodi-
azepines prior to committal to prison. Approximately one-third
of both samples were prescribed opiate medications,
predominantly methadone. 24.7% (23) of new committals
interviewed and 27.8% (25) of the cross-sectional sample
were prescribed antidepressants in the community (see
Table 3).
High risk behaviours and infectious disease
35.5% (33) [95% CI 26.2-45.2] of female committals and
40.7% (37) [95% CI 31.1-50.9] of the cross sectional
sample reported a history of intravenous drug use. 69.7%
(23) [95% CI 52.7-82.6] of intravenous drug users in the
committal sample and 51.4% (23) [95% CI 35.9-66.6] of
intravenous drug users in the cross sectional females had
shared needles. There was a high prevalence of infectious
disease in both samples. Among the committal sample,
29.0% (27) reported testing positive for Hepatitis C, 4.3%
(4) for Hepatitis B and 6.5% (6) for HIV. Among the cross
sectional sample, 34.1% (31) reported testing positive for
Hepatitis C, 2.2% (2) for Hepatitis B and 7.6% (7) for HIV.
(see Table 2).
Psychiatric histories
Mental illnesses and substance use disorders were
common (see Table 4). 34.4% (32) [95% CI 25.5-44.5] of
female committals and 39.6% (36) [95% CI 29.8-49.3] of
the cross-sectional subjects reported a history of contact
with community psychiatric services either as outpatients or
inpatients. 57.8% (53) [95% CI 48.0-67.8] of women inter-
viewed in the cross-sectional sample had contact with
forensic psychiatric services (excluding reports) compared
with only 9.7% (9) [95% CI 5.2-17.4] of female committals. 
Psychosis
A diagnosis of any psychosis included schizophrenia,
schizo-affective disorder, delusional disorder, depressive
disorder with psychotic symptoms, bipolar affective disorder
and drug induced psychosis (ICD-10 F1x.5, F20, F22-29,
F30-31, F32.3, F33.3)
In total 10 of the committal sample and seven of the cross-
sectional sample had a history of a psychotic illness. Table 5
shows the lifetime, six-month and point prevalences of
psychotic illness in the two groups. Of those with a lifetime
history of psychosis, 80% (8) [95% CI 49.0-94.3] of female
committals and 43% (3) [95% CI 15.8-75.0] cross-sectional
subjects had a co-morbid history of substance and/or alco-
hol disorders.
The point prevalence of any psychosis was 5.4% (5) for the
committal sample and 3.3% (3) for the cross sectional
sample. The six-month prevalence of any psychosis was the
same for the committal and cross sectional sample at 5.4%
(5). The lifetime prevalence for any psychosis was 10.8%
(10) for committal women and 7.6% (7) for the cross
sectional sample (see Table 5).
Affective disorders
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Anxiety disorder Female Female
Committals (%) Cross-sectional (%)
[95 % CI] [95 % CI]
Current 6 (6.5) 14 (15.2)
[3.0-13.4] [9.3-23.9]
Six month 8 (8.6) 14 (15.2)
[4.4-16.1] [9.3-23.9]
Lifetime 10 (10.8) 18 (19.6)
[6.0-18.9] [12.7-28.8]
Table 7: Prevalence of anxiety disorder in female prisoners
Any substance Female Female
Committals (%) Cross-sectional (%)
[95 % CI] [95 % CI]
Current 61 (65.6) Not known
[55.5-74.5]
Six month 61 (65.6) 60 (65.2)
[55.5-74.5] [55.1-74.2]
Lifetime 65 (69.9) 64 (71.1)
[59.9-78.3] [59.5-78.0]
Table 8: Prevalence of substance disorders in female prisoners
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Within the committal sample the point prevalence of affec-
tive disorder (includes mild, moderate and severe depression
without psychotic symptoms, and dysthymia) was 10.8%
(10) [95% CI 5.9-18.7]. The six-month prevalence was
14.0% (13) [95% CI 8.4-22.5] and the lifetime prevalence
was 23.7% (22) [95% CI 6.2-33.2]. 
Within the cross-sectional sample the point prevalence of
affective disorder was 16.3% (15) [95% CI 25.2]. The six-
month prevalence was 20.7% (19) [95% CI 3.6-30.0] and
lifetime prevalence was 42.4% (39) [95% CI 32.8-52.6] (see
Table 6).
The point prevalence for a major depressive disorder (ICD-
10 F32-33) was 4.3% (4) for the female committals and 12%
(11) [95% CI 6.8-20.2] for the cross sectional sample. The
six-month prevalence for a depressive disorder was 8.5%
[95% CI 4.4-15.9] for the female committals and 16.3% (15)
[95% CI 10.1-25.2] for the cross sectional sample. The life-
time prevalence of major depressive disorder was 16% (15)
for the female committals and 37% (34) [95% CI 27.8-47.2]
for the cross sectional sample (see Table 6).
Anxiety disorders (ICD-10- DCR 40-42)
Within the committal sample the point prevalence of anxi-
ety disorder was 6.5% (6) [95% CI 3.0-13.4]. The six-month
prevalence was 8.6% (8) [95% CI 4.4-16.1] and the lifetime
prevalence of anxiety disorder was 10.8% (10) [95% CI 6.0-
18.9] (see Table 6).
In the cross-sectional group of women both the point
prevalence and six-month prevalence of anxiety disorders
were 15.2% (14) [95%CI 9.3-23.9]. The lifetime prevalence
for anxiety disorder was 19.6% (18) [95%CI 12.7-28.8] (see
Table 7).
The most common disorders were panic disorder and
phobic disorder. Withdrawal from street drugs is the most
likely explanation for the differences between committal and
cross sectional samples, though the higher reported lifetime
prevalence is difficult to reconcile with this. 
Any mental illness
The point prevalence of any mental illness, (excludes
substance misuse, adjustment disorder and personality disor-
der, includes ICD-10-DCR F1x.5, F20, F22-29, F30-39,
F40-42) was 22.3% (21) [95% CI 15.1-31.8] of the female
committals and 33.7% (31) [95% CI 24.9-43.8] of the cross
sectional sample.  24.5% (23) [95% CI 16.9-34.0] of female
committals compared with 39.6% (36) [95% CI 29.8-49.3]
of the cross sectional sample interviewed had a six-month
prevalence of mental illness. 42.6% (40) [95% CI 33.0-52.6]
of female committals compared with 59.8% (55) [95% CI
49.6-69.2] of the cross sectional sample interviewed had a
lifetime history of mental illness. 
Drug and alcohol histories
Alcohol and drug problems were diagnosed using the cate-
gories of harmful use and dependence syndrome from
ICD-10 Diagnostic Criteria for Research (ICD-10 F1x.1,
F1x.2). Rates of substance misuse were high in both samples
(see Table 8).
Table 8 shows the prevalence of any substance problems,
abuse and dependence, in both samples. 48.4% (45) [95%
CI 38.5-58.4] of the female committals reported a current
drug dependence problem, while 24.7% (23) [95% CI 17.1-
34.4] reported a current alcohol dependence problem. Of
the cross-sectional sample 18.5% (17) [95% CI 11.9-27.6]
of women reported an alcohol dependence problem within
the six months prior to their committal to prison, and 46.7%
(43) [95% CI 36.9-56.9] reported a drug dependence prob-
lem in the six months prior to committal.
45.2% (42) [95% CI 35.4-55.3] of female committals and
42.4% (39) [95% CI 32.8-52.6] of the cross-sectional
sample reported opiate dependence during the year prior to
interview. 
35.5% (33) [95% CI 26.5-45.6] of female committals, and
29.3% (27) [95% CI 21.0-39.3] of the cross-sectional
sample reported they were prescribed methadone mainte-
nance in the community prior to committal. 
Suicidal ideation and suicidal behaviour
38.7% (36) [95% CI 29.4-48.9] of female committals had
self-harmed at some time, 9.6% (9) [95% CI 5.1-17.2] of
these in the last six months. 27.9% (26) [95% CI 19.9-37.8]
of female committals interviewed were recurrent self-harm-
ers, and 11.8% (11) [95% CI 6.7-20.0] reported more than
five episodes of self-harm. The most frequent methods of self-
harm reported were overdose 23.7% (22), self-laceration
22.8% (21) and attempted hanging 11.8% (11).
Within the cross-sectional sample 41.1% (37) [95% CI
30.8-50.4] reported a history of self-harm. 10.9% (10) [95%
CI 6.0-18.9] of these reported an episode in the last six
months. 26.1% (24) [95% CI 18.2-35.9] of the cross-
sectional sample were recurrent self-harmers, and 8.9% (8)
[95% CI 4.5-16.2] reported more than five episodes of self-
harm.
31.2% (29) [95% CI 22.7-41.2] of the committals sample
reported the suicide of a significant person in their lives. An
additional 6.5% (6) [95% CI 2.5-19.6] reported the suicide
of a first-degree relative. In the cross-sectional sample 40.4%
(36) [95% CI 29.8-49.3] reported the suicide of a significant
person in their lives while another 7.9% (7) [95% CI 3.7-14.9]
reported the suicide of a first degree relative. 
Personality disorder
51.4% (37) of 72 screened positive for personality disor-
der. These had higher rates of every type of psychiatric
morbidity when compared to those who did not screen posi-
tive for personality disorder, but only three (4.2%) who were
positive for personality disorder did not have a co-morbid
mental illness or substance dependence or harmful use.
Discussion
This survey of women on committal to prison is one of the
few such studies available.1 This is the first national survey of
psychiatric morbidity amongst prisoners in the Irish prison
system, allowing comparisons to be made with a cross-
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Irish prison study Meta-analysis2
[95% CI] [95% CI] 
N=92 N=2964
Psychosis
(six month prevalence) 5.4% 4%
[2.9-9.6] [3.3-4.7]
Major depressive disorder 
(six month prevalence) 16.3% 12%
[10.1-25.2] [10.9-13.2]
Table 9: Comparison of six-month prevalence rates of psychosis and
depressive disorder in Irish prisons and other jurisdictions
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sectional sample of women on remand and sentenced, and
with the male prisoner population6,7 and with international
averages. 
Weaknesses in the present study
We found that the rate of refusal to take part was high in
this study. While it is possible that those with a psychiatric
history might avoid a psychiatric interview leading to an
under-estimate, it is unlikely that we have over-estimated the
prevalence of mental disorders in the prison population. 
Methodological issues
We were satisfied that the SADS-L used in conjunction
with the ICD-10 Diagnostic Criteria for Research allowed us
to diagnose mental illnesses, even in the presence of a six-
month or lifetime history of alcohol or substance abuse or
dependence. The SADS-L has been well-validated for use in
surveys of general populations8,16 and in prison surveys.8 We
were reliant on the self-report of prisoners to establish the
prevalence of substance misuse following committal.
However continued use of cannabis and other drugs is
common in prison and reliable information about this would
be hard to obtain.
Ethnicity
Irish Travellers were found to be over-represented in both
committal and cross-sectional samples of women prisoners.
Irish Travellers comprise a small proportion of the national
population, estimated at 0.58% in the last census. They are
one of the most marginalized and disadvantaged groups in
Irish society. In a pilot for this survey,17 female travellers had
a relative risk of imprisonment compared to the general
settled community of 12.9, as high an excess as for men from
the Irish Traveller community. This survey is in keeping with
those findings.
Substance misuse
Harmful use and dependence on alcohol and drugs was
prevalent to a similar extent as in male prisoners.5,6 The preva-
lence of benzodiazepine use in this population is particularly
worrying, because of the high prevalence of substance
misuse problems and impulsive self harm.18 The high number
of prisoners receiving prescribed benzodiazepines prior to
committal is of concern in view of their contra-indication for
longer-term treatment, and the level of abuse and depen-
dence on these drugs within prison populations. The
near-complete association between personality disorder and
substance abuse raises interesting questions about the
direction of causation.
The high prevalence of hepatitis C is indicative of the level
of intravenous drug use and the practice of sharing syringes.
There is a discrepancy between the level of opiate use within
these samples and the number in receipt of methadone main-
tenance therapy 
Mental illness
There were few significant differences between the
committal and cross-sectional samples. Major depressive
disorder and anxiety disorders were more common in the
cross-sectional sample, but rates of psychosis and
substance problems were similar.
We have found a greater prevalence of mental illness over-
all in the female prison sample compared to the male Irish
prison samples.5,6 There is also a significant excess preva-
lence of psychosis compared to what is known of the general
Irish population. In a survey of a rural population, a 12-month
prevalence for schizophrenia, schizoaffective disorder, bipolar
and bipolar II disorders combined was 9.3/1000 total female
population, with morbid risk (lifetime prevalence) 17.8/1000
women.19 The excess of mental illness in the female prisoner
samples when compared to the male prisoner samples is
accounted for predominantly by the higher rates of affective
disorders and to a lesser extent, anxiety disorders, within the
cross-sectional group. It is possible that stress incurred upon
the individual by time spent in prison causes higher rates of
anxiety and affective disorders in this population. The acute
effects of withdrawal from alcohol and street drugs such as
cannabis may also contribute.20
The six-month prevalence rates of mental illness can be
broadly compared with studies from other jurisdictions, which
have been summarised in the meta-analysis by Fazel and
Danesh2 (see Table 9). The rate of major depressive disorder
Ir J Psych Med 2006; 23(2): 47-53
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Disorder None
[95 % CI] N=37 [95 % CI] N=35
(%) (%)
Previous time in prison 27 (73)* 14 (40)
[57.0-84.6] [25.6-56.4]
Receiving prescribed medication 27 (73) 15 (42.9)
[57.0-84.6] [28.0-59.1]
Receiving prescribed benzodiazepines 21(56.8)* 4 (11.4)
[40.9-71.3] [4.5-26.0]
Receiving prescribed antidepressants 14 (37.8) 6 (17.1)
[24.1-53.9] [8.1-32.7]
Receiving a prescribed antipsychotic 7 (18.9) 0 (0)
[9.5-34.2] [0.0-9.9]
Contact with child psychiatry services 14 (37.8) 4 (11.4)
[24.1-53.9] [4.5-26.0]
Contact with community psychiatry services 18 (51.4)* 6 (17.1)
[33.4-64.1] [8.1-32.7]
Contact with prison psychiatry services 7 (18.9) 0 (0)
[9.5-34.2] [0.0-9.9]
Ever tried to kill/harm self 22 (59.5)* 7 (20)
[43.5-73.7] [10.0-35.9]
Ever had suicidal thoughts 29 (78.4)* 15 (42.9)
[62.8-88.6] [28.0-59.1]
Current mental illness 17 (45.9)* 0 (0)
[31.0-61.6] [0.0-9.9]
Mental illness in the last six months 19 (51.4)* 0 (0)
[35.9-66.6] [0.0-9.9]
Past mental illness 23 (62.2)* 7 (20.0)
[46.1-75.9] [10.0-35.9]
Current substance problem 29 (78.4) 18 (51.4)
[62.8-88.6] [35.6-67.0]
Lifetime substance problem 31 (83.8) 19 (54.3)
[68.9-92.3] [38.2-69.5]
Current non-psychotic mood disorder 11 (29.7)* 0 (0)
[17.5-45.8] [0.0-9.9]
Table 10: Comparison of female committals with and without
personality disorder
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in the Irish female samples (16.3% for remand and
sentenced combined) was not significantly different from the
international average.   
Various authors have examined the factors that contribute
to the accumulation of the mentally ill in prisons. Penrose
studied prison and mental hospital populations in Europe and
found a negative correlation, which he interpreted to mean
that a constant population of severely mentally ill people
would find institutional care in what ever institution society
chose to provide in a given place at a given time.21 Torrey22 in
America and Gunn23 in the UK both reviewed increases in the
number of mentally ill prisoners coinciding with de-institu-
tionalisation of the mentally ill. Priebe et al identified this trend
as ‘re-institutionalisation’ in six countries.24 Social factors
thought to have a bearing on the large numbers of mentally
ill in prisons include inadequately resourced community
services, homelessness, and co-morbid substance misuse.
In other jurisdictions, services such as police station and
District Court liaison schemes, hospital diversion, and
compulsory community treatment have been well established
for over a decade and shown to be successful.25,26 Within the
Irish jurisdiction the absence of modern mental health legis-
lation dealing with mentally disordered offenders27 and the
lack of services to divert mentally disordered offenders from
the criminal justice system probably contributes to the over-
representation of the mentally ill in prison here.
Service implications
The mental health profile of female prisoners in the Irish
Prison system is characterised by high rates of substance
misuse problems, affective disorders, anxiety disorders and
psychotic disorders. These difficulties occur in a context of
low educational achievement, unemployment, homelessness
and a cycle of family disruption and institutionalisation. The
higher level of mental illness within the cross-sectional
sample suggests that these problems do not resolve during
the period of imprisonment, and may deteriorate. 
Conclusions
These findings highlight the need for a more integrated
approach to the psychiatric care of women in Irish prisons.
The service provided should be at least equivalent in quality
to that available in the community. Currently the psychiatric
care available to mentally ill women in Irish prisons falls short
of that standard in a number of ways. There is incomplete
provision of treatment modalities that would be available in
the community, for example occupational therapy, coun-
selling, and psychology. Patients requiring inpatient hospital
treatment are transferred to a special security hospital (the
Central Mental Hospital) regardless of their security needs.
Acutely disturbed mentally ill prisoners are often confined to
isolation cells, which provide only containment and no thera-
peutic benefit. 
Mental health services for women prisoners should facili-
tate a multidisciplinary delivery of care. This should include
the recruitment of nurses with training in psychiatry to work
in prisons, better screening procedures at committal, and
improved stratification of high-risk individuals within the
prison accommodation, as well as access to adjunctive
services, including occupational therapy, psychology and
counselling services. Greater integration between psychiatric
and drugs services is required to address the high preva-
lence of co-morbidity in this population and the complex chal-
lenges this presents. Community services need to be more
consistent in refusing to prescribe benzodiazepines inappro-
priately. Community services seldom provide access to
dialectic behaviour therapy or related clinical management
strategies for challenging or demanding patients.
The implementation of mental health legislation and
services that would facilitate the diversion of mentally disor-
dered individuals from the criminal justice system to treatment
in the community psychiatric services is urgently required,28
but must also be accompanied by the development of
comprehensive community mental health services, including
local psychiatric intensive care units (ie. acute low secure
units) for challenging or high-risk individuals.29 There is also
an urgent need for more secure psychiatric beds on a
national level. The lack of provision of low secure units and
under provision of community hostel beds in many health
boards should be addressed.30
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